Chris Chan is Vice President, Financial Planning & Analysis at IGM Biosciences, Inc.  Previously Chris was Executive Director of R&D Finance at FibroGen, Inc, and has over 25 years industry experience, including 20 managing clinical trial & R&D finances for biopharmaceutical companies of various sizes.  He holds an MBA from UC Berkeley’s Haas School of Business and is a Certified Management Accountant (CMA) & Certified Financial Manager (CFM). Chris has served as speaker and chair at numerous industry conferences, and has authored multiple published articles on clinical trials budgeting, accruals, and outsourcing.